Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease

NCT00955318 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: KW-6500

Sponsor

Kyowa Kirin Co., Ltd.